Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 1Dr.Reddy's laboratories Limited
03 1USV Private Limited
04 1AmbioPharm, Inc.
05 1Assia Chemical Industries Ltd - Teva Tech Site
06 1Aurobindo Pharma Limited
07 1Azico Biophore India Private Limited
08 1BCN PEPTIDES SA
09 1Chengdu Shengnuo Biopharm Co. Ltd.
10 1FRESENIUS KABI IPSUM SRL
11 1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
12 1MSN Life Sciences Private Limited
01 1ICATIBANT ACETATE
02 1Icatiabant Acetate
03 9Icatibant Acetate
04 1Icatibant acetate
01 1China
02 5India
03 1Israel
04 1Spain
05 1Sweden
06 1Switzerland
07 2U.S.A
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0033
Start Marketing Date : 2007-09-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-994
Start Marketing Date : 2017-10-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0277
Start Marketing Date : 2019-12-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41524-0008
Start Marketing Date : 2017-12-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0526
Start Marketing Date : 2019-04-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-363
Start Marketing Date : 2020-12-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 35207-0008
Start Marketing Date : 2014-07-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 32861-0004
Start Marketing Date : 2014-08-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66558-0197
Start Marketing Date : 2024-01-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66529-0002
Start Marketing Date : 2016-12-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Icatibant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icatibant, including repackagers and relabelers. The FDA regulates Icatibant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icatibant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Icatibant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Icatibant supplier is an individual or a company that provides Icatibant active pharmaceutical ingredient (API) or Icatibant finished formulations upon request. The Icatibant suppliers may include Icatibant API manufacturers, exporters, distributors and traders.
click here to find a list of Icatibant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Icatibant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Icatibant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Icatibant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Icatibant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Icatibant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Icatibant suppliers with NDC on PharmaCompass.
We have 12 companies offering Icatibant
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
